Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony T Reder

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 30, 2002
Type I interferons inhibit interleukin-10 production in activated human monocytes and stimulate IL-10 in T cells: implications for Th1-mediated diseasesXuan Feng, Douglas Yau, Christopher Holbrook, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 10, 2026
Long-Term IFN-β Therapy Enhances and Prolongs IFN Responses in Multiple SclerosisJeffrey Ke, Conrad Moss, Xuan Feng, et al.
CNS Drugs|December 31, 2015
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple SclerosisSamuel F Hunter, James D Bowen, Anthony T Reder
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 2, 2024
Alternative Splicing of RNA Is Excessive in Multiple Sclerosis and Not Linked to Gene Expression Levels: Dysregulation Is Corrected by IFN-βAnthony T Reder, Aika Goel, Tzintzuni Garcia, et al.
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Adeno-associated viral vector-mediated ApoE expression in Alzheimer's disease mice: low CNS immune response, long-term expression, and astrocyte specificityXuan Feng, Fernette F Eide, Hong Jiang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 28, 2022
T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapyAnthony T Reder, Olaf Stuve, Stephanie K Tankou, et al.
American Journal of Therapeutics|September 1, 1995
Eicosenoids Modify Experimental Allergic EncephalomyelitisAnthony T. Reder, Manjula Thapar, Anna Maria Sapugay, et al.
Immunotherapy|October 7, 2020
Asymptomatic brainstem lesions and pachymeningeal enhancement after anti-PD-1 therapyCarlen A Yuen, Kourosh Rezania, Deric M Park, et al.
Journal of Neuroimmunology|March 12, 2024
Novel biomarkers and interferon signature in secondary progressive multiple sclerosisAvital Fogel, Maya Olcer, Aika Goel, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 3, 2023
Prolonged Interferon-Stimulated Gene and Protein Signatures in Multiple Sclerosis Induced by PEGylated IFN-β-1a Compared to Non-PEGylated IFN-β-1aKristi Nguyen, Maya Olcer, Quentin Howlett-Prieto, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 30, 2002
Type I interferons inhibit interleukin-10 production in activated human monocytes and stimulate IL-10 in T cells: implications for Th1-mediated diseasesXuan Feng, Douglas Yau, Christopher Holbrook, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 10, 2026
Long-Term IFN-β Therapy Enhances and Prolongs IFN Responses in Multiple SclerosisJeffrey Ke, Conrad Moss, Xuan Feng, et al.
CNS Drugs|December 31, 2015
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple SclerosisSamuel F Hunter, James D Bowen, Anthony T Reder
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 2, 2024
Alternative Splicing of RNA Is Excessive in Multiple Sclerosis and Not Linked to Gene Expression Levels: Dysregulation Is Corrected by IFN-βAnthony T Reder, Aika Goel, Tzintzuni Garcia, et al.
Frontiers in Bioscience : a Journal and Virtual Library|February 24, 2004
Adeno-associated viral vector-mediated ApoE expression in Alzheimer's disease mice: low CNS immune response, long-term expression, and astrocyte specificityXuan Feng, Fernette F Eide, Hong Jiang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 28, 2022
T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapyAnthony T Reder, Olaf Stuve, Stephanie K Tankou, et al.
American Journal of Therapeutics|September 1, 1995
Eicosenoids Modify Experimental Allergic EncephalomyelitisAnthony T. Reder, Manjula Thapar, Anna Maria Sapugay, et al.
Immunotherapy|October 7, 2020
Asymptomatic brainstem lesions and pachymeningeal enhancement after anti-PD-1 therapyCarlen A Yuen, Kourosh Rezania, Deric M Park, et al.
Journal of Neuroimmunology|March 12, 2024
Novel biomarkers and interferon signature in secondary progressive multiple sclerosisAvital Fogel, Maya Olcer, Aika Goel, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 3, 2023
Prolonged Interferon-Stimulated Gene and Protein Signatures in Multiple Sclerosis Induced by PEGylated IFN-β-1a Compared to Non-PEGylated IFN-β-1aKristi Nguyen, Maya Olcer, Quentin Howlett-Prieto, et al.
Pageof 9